These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2932060)

  • 61. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
    Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
    Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [5'-DFUR (doxifluridine)].
    Taguchi T
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2235-43. PubMed ID: 2955744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group.
    Shimane Breast Cancer Study Group
    Anticancer Res; 2006; 26(1B):591-7. PubMed ID: 16739326
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT].
    Ninomiya Y; Ryu M; Matsuura N; Fujimoto K; Miwa M; Ishitsuka H
    Gan To Kagaku Ryoho; 1988 May; 15(5):1747-54. PubMed ID: 2967050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Antitumor effects of 5'-deoxy-5-fluorouridine (5'-DFUR) against various murine tumors in combination with recombinant interferon alpha or cytostatics].
    Ninomiya Y; Miwa M; Fukuda H; Ishikawa T; Eda H; Matsuura N; Tanaka Y; Ishitsuka H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3271-7. PubMed ID: 2961305
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
    Futatsuki K; Komita T; Kamano T; Watanabe H
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [A case of recurrent breast cancer responding to long-term treatment with 5'-DFUR combined with MPA].
    Kimura M; Koida T; Sekihara M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1183-5. PubMed ID: 8751807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The serum and tissue concentration of FT-207, 5'-DFUR and 5-FU in patients with breast cancer by preoperative administration of UFT and 5'-DFUR].
    Kosaka A; Sumiyoshi K; Ando J
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):277-80. PubMed ID: 2521996
    [No Abstract]   [Full Text] [Related]  

  • 70. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
    Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Kobayashi T; Kimura T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1521-6. PubMed ID: 11015996
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
    Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Efficacy and safety of novel oral fluoropyrimidine anticancer drug, TS-1 for advanced and recurrent gastric cancer patients].
    Arai K; Iwasaki Y; Kimura Y; Takahashi K; Yamaguchi T; Honma S; Takahashi T
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1297-301. PubMed ID: 14518409
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination therapy by trastuzumab with 5'-deoxy-5-fluorouridine and cyclophosphamide in patients with metastatic breast cancer.
    Saito Y; Suzuki Y; Tokuda Y
    Tokai J Exp Clin Med; 2009 Sep; 34(3):106-11. PubMed ID: 21319009
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
    Yamashita T; Yamashita H; Itoh Y; Karamatsu S; Itoh K; Hara Y; Ando Y; Sugiura H; Kuzushima T; Toyama T; Iwata H; Kobayashi S; Iwase H
    Breast Cancer; 2006; 13(4):334-9. PubMed ID: 17146158
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effect of preoperative oral 5'-DFUR on PyNPase level in gastrointestinal malignant tumor tissues].
    Wang WJ; Shi D; Wang SM
    Ai Zheng; 2003 Jun; 22(6):653-7. PubMed ID: 12948420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
    Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose.
    Tazawa K; Sakamoto T; Kuroki Y; Yamashita I; Okamoto M; Katuyama S; Fujimaki M
    Clin Exp Metastasis; 1997 May; 15(3):266-71. PubMed ID: 9174128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Two cases of pulmonary metastasis of colorectal cancer successfully treated with oral 5'-DFUR].
    Kato M; Sawai K; Noguchi A; Minato H; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2239-43. PubMed ID: 1444492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comparison of gastrointestinal toxicity of 5-FU derivatives].
    Imamura I; Yabumoto M; Fukui H; Wada H; Takechi T; Takeda S; Yamada Y
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1231-6. PubMed ID: 8333750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.